• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎性小体激活加重骨髓 ACAT1(酰基辅酶 A:胆固醇酰基转移酶 1)缺陷小鼠的皮肤黄色瘤和动脉粥样硬化

Inflammasome Activation Aggravates Cutaneous Xanthomatosis and Atherosclerosis in ACAT1 (Acyl-CoA Cholesterol Acyltransferase 1) Deficiency in Bone Marrow.

机构信息

From the Division of Endocrinology and Metabolism, Department of Internal Medicine (T.W., M.T., D.Y., A.T., S.T., H.Y., S.N., K.E., S.I.), Jichi Medical University, Shimotsuke, Japan.

Division of Inflammation Research, Center for Molecular Medicine (T.K., M.T.), Jichi Medical University, Shimotsuke, Japan.

出版信息

Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2576-2589. doi: 10.1161/ATVBAHA.118.311648.

DOI:10.1161/ATVBAHA.118.311648
PMID:30354239
Abstract

Objective- ACAT1 (Acyl-CoA cholesterol acyltransferase 1) esterifies cellular free cholesterol, thereby converting macrophages to cholesteryl ester-laden foam cells in atherosclerotic lesions and cutaneous xanthoma. Paradoxically, however, loss of ACAT1 in bone marrow causes the aggravation of atherosclerosis and the development of severe cutaneous xanthoma in hyperlipidemic mice. Recently, it has been reported that cholesterol crystals activate NLRP3 (NACHT, LRR [leucine-rich repeats], and PYD [pyrin domain] domain-containing protein 3) inflammasomes, thereby contributing to the development of atherosclerosis. The present study aimed to clarify the role of NLRP3 inflammasomes in the worsening of atherosclerosis and cutaneous xanthoma induced by ACAT1 deficiency. Approach and Results- Ldlr-null mice were transplanted with bone marrow from WT (wild type) mice and mice lacking ACAT1, NLRP3, or both. After the 4 types of mice were fed high-cholesterol diets, we compared their atherosclerosis and skin lesions. The mice transplanted with Acat1-null bone marrow developed severe cutaneous xanthoma, which was filled with numerous macrophages and cholesterol clefts and had markedly increased expression of inflammatory cytokines, and increased atherosclerosis. Loss of NLRP3 completely reversed the cutaneous xanthoma, whereas it improved the atherosclerosis only partially. Acat1-null peritoneal macrophages showed enhanced expression of CHOP (C/EBP [CCAAT/enhancer binding protein] homologous protein) and TNF-α (tumor necrosis factor-α) but no evidence of inflammasome activation, after treatment with acetylated LDL (low-density lipoprotein). Conclusions- Elimination of ACAT1 in bone marrow-derived cells aggravates cutaneous xanthoma and atherosclerosis. The development of cutaneous xanthoma is induced mainly via the NLRP3 inflammasome activation.

摘要

目的- ACAT1(酰基辅酶 A 胆固醇酰基转移酶 1)酯化细胞内游离胆固醇,从而将巨噬细胞转化为动脉粥样硬化病变和皮肤黄色瘤中的胆固醇酯负荷泡沫细胞。然而,具有讽刺意味的是,骨髓中 ACAT1 的缺失会导致动脉粥样硬化的加重和高脂血症小鼠严重皮肤黄色瘤的发生。最近,有报道称胆固醇晶体激活 NLRP3(NACHT、LRR[富含亮氨酸重复序列]和 PYD[吡嗪结构域]结构域蛋白 3)炎性小体,从而促进动脉粥样硬化的发展。本研究旨在阐明 NLRP3 炎性小体在 ACAT1 缺乏引起的动脉粥样硬化和皮肤黄色瘤恶化中的作用。

方法和结果- 将 Ldlr-/- 小鼠的骨髓移植到 WT(野生型)小鼠和缺乏 ACAT1、NLRP3 或两者的小鼠中。在 4 种类型的小鼠喂食高胆固醇饮食后,我们比较了它们的动脉粥样硬化和皮肤病变。移植 Acat1-/-骨髓的小鼠发生严重的皮肤黄色瘤,充满大量巨噬细胞和胆固醇裂隙,炎症细胞因子表达明显增加,并伴有明显的动脉粥样硬化。NLRP3 的缺失完全逆转了皮肤黄色瘤,而仅部分改善了动脉粥样硬化。用乙酰化 LDL(低密度脂蛋白)处理后,Acat1-/-腹腔巨噬细胞显示 CHOP(CCAAT/增强子结合蛋白同源蛋白)和 TNF-α(肿瘤坏死因子-α)的表达增强,但没有炎性小体激活的证据。

结论- 骨髓来源细胞中 ACAT1 的缺失加剧了皮肤黄色瘤和动脉粥样硬化。皮肤黄色瘤的发展主要是通过 NLRP3 炎性小体的激活诱导的。

相似文献

1
Inflammasome Activation Aggravates Cutaneous Xanthomatosis and Atherosclerosis in ACAT1 (Acyl-CoA Cholesterol Acyltransferase 1) Deficiency in Bone Marrow.炎性小体激活加重骨髓 ACAT1(酰基辅酶 A:胆固醇酰基转移酶 1)缺陷小鼠的皮肤黄色瘤和动脉粥样硬化
Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2576-2589. doi: 10.1161/ATVBAHA.118.311648.
2
Loss of ACAT1 Attenuates Atherosclerosis Aggravated by Loss of NCEH1 in Bone Marrow-Derived Cells.载脂蛋白 ACAT1 缺失可减轻骨髓源性细胞中 NCEH1 缺失导致的动脉粥样硬化加重。
J Atheroscler Thromb. 2019 Mar 1;26(3):246-259. doi: 10.5551/jat.44040. Epub 2018 Oct 4.
3
Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1.缺乏酰基辅酶A:胆固醇酰基转移酶1的高脂血症小鼠中的大量黄瘤病和动脉粥样硬化病变组成改变。
J Clin Invest. 2000 Mar;105(6):711-9. doi: 10.1172/JCI9021.
4
Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.胆固醇外排途径抑制炎症小体激活、NETosis 和动脉粥样硬化形成。
Circulation. 2018 Aug 28;138(9):898-912. doi: 10.1161/CIRCULATIONAHA.117.032636.
5
Myeloid Acyl-CoA:Cholesterol Acyltransferase 1 Deficiency Reduces Lesion Macrophage Content and Suppresses Atherosclerosis Progression.髓系酰基辅酶A:胆固醇酰基转移酶1缺乏症可降低病变巨噬细胞含量并抑制动脉粥样硬化进展。
J Biol Chem. 2016 Mar 18;291(12):6232-44. doi: 10.1074/jbc.M116.713818. Epub 2016 Jan 21.
6
Myeloid HMG-CoA (3-Hydroxy-3-Methylglutaryl-Coenzyme A) Reductase Determines Atherosclerosis by Modulating Migration of Macrophages.髓样 HMG-CoA(3-羟-3-甲基戊二酰辅酶 A)还原酶通过调节巨噬细胞迁移来决定动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2590-2600. doi: 10.1161/ATVBAHA.118.311664.
7
Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.造血细胞中Jnk1缺陷抑制巨噬细胞凋亡并增加低密度脂蛋白受体缺失小鼠的动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1122-31. doi: 10.1161/ATVBAHA.116.307580. Epub 2016 Apr 21.
8
Ogg1-Dependent DNA Repair Regulates NLRP3 Inflammasome and Prevents Atherosclerosis.依赖Ogg1的DNA修复调节NLRP3炎性小体并预防动脉粥样硬化。
Circ Res. 2016 Sep 2;119(6):e76-90. doi: 10.1161/CIRCRESAHA.116.308362. Epub 2016 Jul 6.
9
Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis.曲尼司特在调控 NLRP3 泛素化、血管炎症和动脉粥样硬化中的新作用
J Am Heart Assoc. 2020 Jun 16;9(12):e015513. doi: 10.1161/JAHA.119.015513. Epub 2020 Jun 1.
10
NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.MCC950对NLRP3炎性小体的抑制作用可减少载脂蛋白E缺乏小鼠的动脉粥样硬化病变发展——简要报告
Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1457-1461. doi: 10.1161/ATVBAHA.117.309575. Epub 2017 Jun 8.

引用本文的文献

1
Molecular Network Analysis and Effector Gene Prioritization of Endurance-Training-Influenced Modulation of Cardiac Aging.耐力训练对心脏衰老影响的分子网络分析及效应基因排序
Genes (Basel). 2025 Jul 11;16(7):814. doi: 10.3390/genes16070814.
2
Inflammasome Activation and Neutrophil Extracellular Traps in Atherosclerosis.动脉粥样硬化中的炎性小体激活与中性粒细胞胞外诱捕网
J Atheroscler Thromb. 2025 May 1;32(5):535-549. doi: 10.5551/jat.RV22033. Epub 2025 Jan 18.
3
Serum 25-hydroxycholesterol levels are increased in patients with coronavirus disease 2019.
血清 25-羟胆固醇水平在 2019 冠状病毒病患者中升高。
J Clin Lipidol. 2023 Jan-Feb;17(1):78-86. doi: 10.1016/j.jacl.2022.10.012. Epub 2022 Nov 6.
4
Sericin-mediated improvement of dysmorphic cardiac mitochondria from hypercholesterolaemia is associated with maintaining mitochondrial dynamics, energy production, and mitochondrial structure.丝胶蛋白介导改善高胆固醇血症引起的心脏线粒体形态异常,这与维持线粒体动力学、能量产生及线粒体结构有关。
Pharm Biol. 2022 Dec;60(1):708-721. doi: 10.1080/13880209.2022.2055088.
5
Formation and Cellular Impact of Cholesterol Crystals in Health and Disease.胆固醇晶体在健康和疾病中的形成及细胞影响。
Adv Biol (Weinh). 2021 Nov;5(11):e2100638. doi: 10.1002/adbi.202100638. Epub 2021 Sep 29.
6
Soat1 mediates the mouse strain effects on cholesterol loading-induced endoplasmic reticulum stress and CHOP expression in macrophages.Soat1 介导了胆固醇负荷诱导的内质网应激和 CHOP 表达在巨噬细胞中的小鼠品系效应。
Biochim Biophys Acta Mol Cell Biol Lipids. 2021 Jan;1866(1):158825. doi: 10.1016/j.bbalip.2020.158825. Epub 2020 Oct 6.
7
Annual Report on Sex in Preclinical Studies: Publications in 2018.临床前研究中的性别年度报告:2018年出版物
Arterioscler Thromb Vasc Biol. 2020 Jan;40(1):e1-e9. doi: 10.1161/ATVBAHA.119.313556. Epub 2019 Dec 23.
8
Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation.靶向 NLRP3 炎性小体治疗炎症性肠病:扑灭炎症之火。
Inflammation. 2019 Aug;42(4):1147-1159. doi: 10.1007/s10753-019-01008-y.
9
Updates on Approaches for Studying Atherosclerosis.动脉粥样硬化研究方法的最新进展。
Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):e108-e117. doi: 10.1161/ATVBAHA.119.312001.